Cardurion Pharmaceuticals Appoints Rebecca Frey as Chief Operating Officer
CAMBRIDGE, MASS. – [July 24, 2018] – Cardurion Pharmaceuticals, a biotechnology company focused on the development of novel, next-generation therapeutics for the treatment of cardiovascular [...]
